Ultragenyx Pharmaceutical (RARE) Non Operating Income (2013 - 2017)
Ultragenyx Pharmaceutical's Non Operating Income came in at $4.49 million for Q3 2017, up 412.6% from $876,000 a year earlier but down 19.3% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Non Operating Income (2013 - 2017) Analysis & Trends
Over the trailing twelve months to Sep 30, 2017, Ultragenyx Pharmaceutical reported Non Operating Income of $11.02 million, up 189.2% year-over-year; for FY2016, it was $2.17 million, up 2.3% from FY2015.
- Going back by year, Non Operating Income was $2.12 million in FY2015, -$3.02 million in FY2014, -$2.79 million in FY2013 and -$349,000 in FY2012.
- The five-year range for quarterly Non Operating Income is -$3.29 million (Q1 2014) to $5.56 million (Q2 2017).
- Year-over-year, Non Operating Income has increased for three consecutive quarters, with growth averaging 300.1% over the last seven quarters.
- Over the past five years, the year-over-year growth in Non Operating Income ranged from 24.4% (Q3 2016) to 603.3% (Q1 2016).
- Business Quant data shows RARE's Non Operating Income at $5.56 million (Q2 2017), $1.66 million (Q1 2017) and -$703,000 (Q4 2016) in the three quarters before Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 4.49 Mn |
| Jun 30, 2017 | 5.56 Mn |
| Mar 31, 2017 | 1.66 Mn |
| Dec 31, 2016 | -703,000.00 |
| Sep 30, 2016 | 876,000.00 |
| Jun 30, 2016 | 1.13 Mn |
| Mar 31, 2016 | 865,000.00 |
| Dec 31, 2015 | 938,000.00 |
| Sep 30, 2015 | 704,000.00 |
| Jun 30, 2015 | 355,000.00 |
| Mar 31, 2015 | 123,000.00 |
| Dec 31, 2014 | 205,000.00 |
| Sep 30, 2014 | -14,000.00 |
| Jun 30, 2014 | 76,000.00 |
| Mar 31, 2014 | -3.29 Mn |
| Dec 31, 2013 | -1.79 Mn |
| Sep 30, 2013 | -667,000.00 |
API Access
Ultragenyx Pharmaceutical Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();